Dynavax Allergic Rhinitis TOLAMBA Trial

Trial Profile

Dynavax Allergic Rhinitis TOLAMBA Trial

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 13 Feb 2007

At a glance

  • Drugs Ragweed allergy immunotherapy 1018-ISS conjugate (Primary)
  • Indications Seasonal allergic rhinitis
  • Focus Registrational; Therapeutic Use
  • Acronyms DARTT
  • Sponsors Dynavax Technologies
  • Most Recent Events

    • 13 Feb 2007 Interim 1-year results reported. Added to VAX.
    • 26 Jun 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top